Latest THC Analyst Ratings & Recommendations
Recent analyst recommendations with rating changes and price target updates (last 90 days)
| Date | Analyst | Firm | Action | Rating | Price Target |
|---|---|---|---|---|---|
| Jason Cassorla | Guggenheim | Reiterates | Buy | $283.00 → $307.00 +24.00 (+8.5%) | |
| Craig Hettenbach | Morgan Stanley | Reiterates | Buy | $274.00 | |
| Ben Hendrix | RBC Capital | Maintains | Buy | $283.00 | |
| Zacks Equity Research | Zacks Equity Research | Initiates Coverage | Hold | - | |
| Andrew Cooper | Raymond James | Reiterates | Buy | $285.00 | |
| Piyali Saha Sikdar | Zacks Equity Research | Initiates Coverage | Buy | - | |
| Sean Dodge | BMO Capital | Initiates | Hold | $265.00 | |
| Whit Mayo | Leerink Partners | Reiterates | Buy | - | |
| Whit Mayo | Leerink Partners | Reiterates | Buy | - | |
| Craig Hettenbach | Morgan Stanley | Maintains | Buy | $274.00 | |
| Benjamin Rossi | JP Morgan | Maintains | Buy | $315.00 | |
| Shaun Pruitt | Zacks Equity Research | Initiates Coverage | Buy | - | |
| Benjamin Rossi | JP Morgan | Maintains | Buy | $315.00 | |
| A.J. Rice | UBS | Maintains | Buy | $308.00 | |
| Ann Hynes | Mizuho | Maintains | Buy | $250.00 → $290.00 +40.00 (+16.0%) | |
| Kevin Fischbeck | BofA Securities | Reiterates | Buy | $290.00 → $295.00 +5.00 (+1.7%) | |
| Stephen Baxter | Wells Fargo | Initiates Coverage | Buy | $231.00 → $281.00 +50.00 (+21.6%) | |
| Scott Fidel | Goldman Sachs | Initiates Coverage | Buy | $252.00 → $305.00 +53.00 (+21.0%) | |
| David S Macdonald | Truist | Reiterates | Buy | $270.00 → $290.00 +20.00 (+7.4%) | |
| Michael Ha | Baird | Maintains | Hold | $210.00 → $280.00 +70.00 (+33.3%) | |
| Raj Kumar CFA | Stephens | Maintains | Buy | $250.00 → $285.00 +35.00 (+14.0%) | |
| Ryan Langston | TD Cowen | Initiates Coverage | Buy | $233.00 → $263.00 +30.00 (+12.9%) |
